Drew Burch

Drew Burch has over 30 years of strategic, operational, commercial and financial experiences in the life sciences industry. Prior to joining Maravai, he was President, Softgels at Thermo Fisher Scientific, where he led the division’s CDMO services in the U.S. and Europe. He also held multiple leadership positions across other Thermo Fisher Scientific’s business segments, including Instrument and Enterprise Services and European Drug Product Division as President, and Life Sciences Solutions as Vice President, Strategy and Business Development. Previously, Mr. Burch worked as an advisor to healthcare companies on M&A during his tenures at Barclays Capital, Lehman Brothers and Merrill Lynch & Co. He holds an MBA from Stanford University Graduate School of Business and a BA in economics and political science from Yale University.